Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
The Journal of Urology|July 20, 1999
Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patientsJ W Moul, R R Connelly, R M Mooneyhan, et al.
Surgery|August 1, 1996
Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancerJ W Moul, M C Bettencourt, I A Sesterhenn, et al.
International Journal of Epidemiology|May 23, 2001
Prostate cancer, benign prostatic hyperplasia and physical activity in Shanghai, ChinaJ V Lacey, J Deng, M Dosemeci, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 6, 2001
Body size and prostate cancer: a population-based case-control study in ChinaA W Hsing, J Deng, I A Sesterhenn, et al.
The Journal of Urology|November 24, 1999
p53 and bcl-2 immunohistochemistry in pretreatment prostate needle biopsies to predict recurrence of prostate cancer after radical prostatectomyG B Stackhouse, I A Sesterhenn, J J Bauer, et al.
The American Journal of Surgical Pathology|August 1, 1987
Liesegang rings in tissue. How to distinguish Liesegang rings from the giant kidney worm, Dioctophyma renaleS M Tuur, A M Nelson, D W Gibson, et al.
The Journal of Urology|November 1, 1994
Characteristics of prostate cancer detected in the American Cancer Society-National Prostate Cancer Detection ProjectC Mettlin, G P Murphy, F Lee, et al.
Cancer|September 1, 1993
Characteristics of prostate cancers detected in a multimodality early detection program. The Investigators of the American Cancer Society-National Prostate Cancer Detection ProjectC Mettlin, G P Murphy, F Lee, et al.
The Prostate|July 12, 2002
Insulin-like growth factors and risk of benign prostatic hyperplasiaAnand P Chokkalingam, Yu-Tang Gao, Jie Deng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup StudyI A Sesterhenn, R B Weiss, F K Mostofi, et al.
Pageof 9